DCAI Dialysis of America (MM)

Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of Dialysis Corporation of America, Inc. (“DCA” or the “Company”) (NASDAQ:DCAI) related to the Company’s agreement to be acquired by U.S. Renal Care, Inc. (“USRC”), a privately held company. The proposed transaction is valued at approximately $112 million.

Under the terms of the definitive merger agreement entered into by the parties, USRC, through a subsidiary, will commence a tender offer for all of the outstanding common shares of DCA for $11.25 per share in cash, followed by a merger to acquire all remaining outstanding DCA shares at the same cash price paid in the tender offer. USRC expects to commence the tender offer promptly, and anticipates the transaction will close in May 2010. The investigation concerns possible breaches of fiduciary duty and other violations of law related to approval of the transaction by DCA’s board of directors.

If you own shares of DCA, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.

Dialysis OF America (NASDAQ:DCAI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024

Dialysis OF America (NASDAQ:DCAI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024